[UPDATE, August 1, 2018: Abacus and Expensify agreed to dismiss all claims. More information here.] [UPDATE, Aug. 18, 2017: Abacus Labs Inc. asked the U.S. District Court for the Southern District of New York to dismiss Expensify’s claims because, Abacus argued, the patents in question are not valid. “These patents are directed to the abstract idea of correlating unreadable information…

The full content is available to subscribers

Lost your password?

Reminder: As per our Subscriber Agreement, reproduction or distribution of content and sharing user names and passwords are strictly prohibited.